- Tumor stage in relation to tumor site and tumor markers (AFP, Beta- HCG).
| Stage | n (%) | Site | AFP | Beta-HCG |
|---|---|---|---|---|
| Stage 1 | 18 (37.5) | ◾ Testes: 13 patients ◾ Ovaries: 4 patients ◾ Sacro-coccyx: 1 patient | Normal 5 patients High: 13 patients | Normal: 13 patients High: 1 patient Missing: 4 patients |
| Stage 2 | 6 (12.5%) | ◾ Testes: 1 patient ◾ Ovaries: 2 patients ◾ Sacro-coccyx: 1 patient ◾ Retroperitoneum: 1 patient ◾ Abdomen: 1 patient | Normal: 2 patients High: 4 patients | Normal: 6 patients |
| Stage 3 | 10 (20.8) | ◾ Ovaries: 7 patients ◾ Sacro-coccyx: 1 patient ◾ Retroperitoneum: 1 patient ◾ Mediastinum: 1 patient | Normal: 3 patients High: 7 patients | Normal: 7 patients High: 2 patients Missing: 1 patient |
| Stage 4 | 14 (29.1%) | ◾ Testes: 2 patients ◾ Ovaries: 4 patients ◾ Sacro-coccyx: 4 patients ◾ Abdomen: 2 patients ◾ Mediastinum: 1 patient ◾ Intra-orbital: 1 patient | Normal: 3 patients High: 9 patients Missing: 4 patients | Normal: 8 patients High: 3 patients Missing: 3 patient |
AFP: α-1-fetoprotein, HCG: human chorionic gonadotropin